Results
|
481.
|
|
|
482.
|
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial. [electronic resource] by
- Park, Keunchil
- Tan, Eng-Huat
- O'Byrne, Ken
- Zhang, Li
- Boyer, Michael
- Mok, Tony
- Hirsh, Vera
- Yang, James Chih-Hsin
- Lee, Ki Hyeong
- Lu, Shun
- Shi, Yuankai
- Kim, Sang-We
- Laskin, Janessa
- Kim, Dong-Wan
- Arvis, Catherine Dubos
- Kölbeck, Karl
- Laurie, Scott A
- Tsai, Chun-Ming
- Shahidi, Mehdi
- Kim, Miyoung
- Massey, Dan
- Zazulina, Victoria
- Paz-Ares, Luis
Producer: 20170613
In:
The Lancet. Oncology vol. 17
Availability: No items available.
|
|
483.
|
YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells. [electronic resource] by
- Cheng, Chun-Chia
- Chang, Jungshan
- Huang, Stanley Ching-Cheng
- Lin, Huan-Chau
- Ho, Ai-Sheng
- Lim, Ken-Hong
- Chang, Chun-Chao
- Huang, Ling
- Chang, Yu-Cheng
- Chang, Yi-Fang
- Wu, Cheng-Wen
Producer: 20171004
In:
PloS one vol. 12
Availability: No items available.
|
|
484.
|
Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program. [electronic resource] by
- Moehler, Markus
- Maderer, Annett
- Ehrlich, Anne
- Foerster, Friedrich
- Schad, Arno
- Nickolay, Tanja
- Ruckes, Christian
- Weinmann, Arndt
- Sivanathan, Visvakanth
- Marquardt, Jens U
- Galle, Peter Robert
- Woerns, Marcus
- Thomaidis, Thomas
Producer: 20190423
In:
BMC cancer vol. 19
Availability: No items available.
|
|
485.
|
Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol. [electronic resource] by
- Levy, Benjamin
- Paz-Ares, Luis
- Bennouna, Jaafar
- Felip, Enriqueta
- Abreu, Delvys Rodríguez
- Isla, Dolores
- Barlesi, Fabrice
- Molinier, Olivier
- Madelaine, Jeannick
- Audigier-Valette, Clarisse
- Kim, Sang-We
- Kim, Hye Ryun
- Ozguroglu, Mustafa
- Erman, Mustafa
- Badin, Firas Benyamine
- Mekhail, Tarek M
- Scheff, Ronald
- Chisamore, Michael J
- Sadrolhefazi, Behbood
- Riess, Jonathan W
Producer: 20200403
In:
Clinical lung cancer vol. 20
Availability: No items available.
|
|
486.
|
Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer. [electronic resource] by
- Kang, Han Na
- Kim, Jae-Hwan
- Park, A-Young
- Choi, Jae Woo
- Lim, Sun Min
- Kim, Jinna
- Shin, Eun Joo
- Hong, Min Hee
- Pyo, Kyoung-Ho
- Yun, Mi Ran
- Kim, Dong Hwi
- Lee, Hanna
- Yoon, Sun Och
- Kim, Da Hee
- Park, Young Min
- Byeon, Hyung Kwon
- Jung, Inkyung
- Paik, Soonmyung
- Koh, Yoon Woo
- Cho, Byoung Chul
- Kim, Hye Ryun
Producer: 20201218
In:
BMC cancer vol. 20
Availability: No items available.
|
|
487.
|
Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors. [electronic resource] by
- Slobbe, Paul
- Windhorst, Albert D
- Stigter-van Walsum, Marijke
- Schuit, Robert C
- Smit, Egbert F
- Niessen, Heiko G
- Solca, Flavio
- Stehle, Gerd
- van Dongen, Guus A M S
- Poot, Alex J
Producer: 20150514
In:
Nuclear medicine and biology vol. 41
Availability: No items available.
|
|
488.
|
|
|
489.
|
|
|
490.
|
|
|
491.
|
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial. [electronic resource] by
- Schuler, M
- Yang, J C-H
- Park, K
- Kim, J-H
- Bennouna, J
- Chen, Y-M
- Chouaid, C
- De Marinis, F
- Feng, J-F
- Grossi, F
- Kim, D-W
- Liu, X
- Lu, S
- Strausz, J
- Vinnyk, Y
- Wiewrodt, R
- Zhou, C
- Wang, B
- Chand, V K
- Planchard, D
Producer: 20161213
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|
|
492.
|
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2 [electronic resource] by
- Xu, Xiaowei
- De Angelis, Carmine
- Burke, Kathleen A
- Nardone, Agostina
- Hu, Huizhong
- Qin, Lanfang
- Veeraraghavan, Jamunarani
- Sethunath, Vidyalakshmi
- Heiser, Laura M
- Wang, Nicholas
- Ng, Charlotte K Y
- Chen, Edward S
- Renwick, Alexander
- Wang, Tao
- Nanda, Sarmistha
- Shea, Martin
- Mitchell, Tamika
- Rajendran, Mahitha
- Waters, Ian
- Zabransky, Daniel J
- Scott, Kenneth L
- Gutierrez, Carolina
- Nagi, Chandandeep
- Geyer, Felipe C
- Chamness, Gary C
- Park, Ben H
- Shaw, Chad A
- Hilsenbeck, Susan G
- Rimawi, Mothaffar F
- Gray, Joe W
- Weigelt, Britta
- Reis-Filho, Jorge S
- Osborne, C Kent
- Schiff, Rachel
Producer: 20180619
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 23
Availability: No items available.
|
|
493.
|
|
|
494.
|
|
|
495.
|
|
|
496.
|
Synergistic Growth Inhibition by Afatinib and Trametinib in Preclinical Oral Squamous Cell Carcinoma Models. [electronic resource] by
- Yee, Pei San
- Zainal, Nur Syafinaz
- Gan, Chai Phei
- Lee, Bernard K B
- Mun, Kein Seong
- Abraham, Mannil Thomas
- Ismail, Siti Mazlipah
- Abdul Rahman, Zainal Ariff
- Patel, Vyomesh
- Cheong, Sok Ching
Producer: 20200109
In:
Targeted oncology vol. 14
Availability: No items available.
|
|
497.
|
|
|
498.
|
Rationale for Using Irreversible Epidermal Growth Factor Receptor Inhibitors in Combination with Phosphatidylinositol 3-Kinase Inhibitors for Advanced Head and Neck Squamous Cell Carcinoma. [electronic resource] by
- Michmerhuizen, Nicole L
- Leonard, Elizabeth
- Matovina, Chloe
- Harris, Micah
- Herbst, Gabrielle
- Kulkarni, Aditi
- Zhai, Jingyi
- Jiang, Hui
- Carey, Thomas E
- Brenner, J Chad
Producer: 20190617
In:
Molecular pharmacology vol. 95
Availability: No items available.
|
|
499.
|
First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials. [electronic resource] by
- Schuler, Martin
- Paz-Ares, Luis
- Sequist, Lecia V
- Hirsh, Vera
- Lee, Ki Hyeong
- Wu, Yi-Long
- Lu, Shun
- Zhou, Caicun
- Feng, Jifeng
- Ellis, Stuart H
- Samuelsen, Carl H
- Tang, Wenbo
- Märten, Angela
- Ehrnrooth, Eva
- Park, Keunchil
- Yang, James Chih-Hsin
Producer: 20200305
In:
Lung cancer (Amsterdam, Netherlands) vol. 133
Availability: No items available.
|
|
500.
|
Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer. [electronic resource] by
- Montanuy, Helena
- Martínez-Barriocanal, Águeda
- Antonio Casado, José
- Rovirosa, Llorenç
- Ramírez, Maria José
- Nieto, Rocío
- Carrascoso-Rubio, Carlos
- Riera, Pau
- González, Alan
- Lerma, Enrique
- Lasa, Adriana
- Carreras-Puigvert, Jordi
- Helleday, Thomas
- Bueren, Juan A
- Arango, Diego
- Minguillón, Jordi
- Surrallés, Jordi
Producer: 20210913
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26
Availability: No items available.
|